Lund et al., 1996 - Google Patents
Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and-dependent pathwaysLund et al., 1996
View PDF- Document ID
- 7036912664368200270
- Author
- Lund L
- Rømer J
- Thomasset N
- Solberg H
- Pyke C
- Bissell M
- Danø K
- Werb Z
- Publication year
- Publication venue
- Development
External Links
Snippet
Postlactational involution of the mammary gland is characterized by two distinct physiological events: apoptosis of the secretory, epithelial cells undergoing programmed cell death, and proteolytic degradation of the mammary gland basement membrane. We …
- 230000006907 apoptotic process 0 title abstract description 23
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lund et al. | Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and-dependent pathways | |
| Fang et al. | Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-β | |
| Radisky et al. | Stromal induction of breast cancer: inflammation and invasion | |
| Mignatti et al. | Plasminogen activators and matrix metalloproteinases in angiogenesis | |
| Pyke et al. | Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer | |
| Lemjabbar et al. | Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: effects of steroid and immunosuppressive treatment | |
| Kawano et al. | Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin (ogen) in lung neoplasms: an immunohistochemical study | |
| Saarialho-Kere et al. | Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium | |
| Newman et al. | Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall | |
| Galis et al. | Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. | |
| Mendes et al. | Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model | |
| Vassalli et al. | The plasminogen activator/plasmin system. | |
| Basset et al. | Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review | |
| Deryugina et al. | Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis | |
| Cho et al. | Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma | |
| Tryggvason et al. | Type IV collagenases in invasive tumors | |
| Madlener et al. | Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair | |
| Mazzieri et al. | Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants | |
| Pérez-ramos et al. | Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis | |
| Plaisier et al. | Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP | |
| Duffy et al. | Plasminogen activator and cancer | |
| Yang et al. | Tumor necrosis factor-α-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: molecular basis linking ovulation and cancer risk | |
| US20080166354A1 (en) | Suppression of inhibitors | |
| Friess et al. | Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis | |
| Rømer et al. | Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion |